SCHEMBL9953047

SCHEMBL9953047

N=C(N)c1coc2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAOB P27338 15/20 0.49
ADORA2B P29275 2/20 0.41
MAPT P10636 4/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
TP53 P04637 1/20 0.41
IDO1 P14902 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
MAOA P21397 4/20 0.39
PTPN1 P18031 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2301535 0.80 MAOB (0.58) MAOBADORA2BMAPTNPC1RAB9A
SCHEMBL8761733 0.75 MAOB (0.61) MAOBADORA2BMAPTNPC1RAB9A
SCHEMBL2123943 0.74 EED (0.41) MAOBHPGDHSD17B10MAOAALDH1A1
SCHEMBL70456 0.73 MAOB (0.76) MAOBADORA2BMAPTNPC1RAB9A
SCHEMBL31314554 0.73 MAOB (0.50) MAOBADORA2BMAPTNPC1RAB9A
SCHEMBL5158204 0.73 MAOB (0.50) MAOBADORA2BMAPTNPC1RAB9A
SCHEMBL1299217 0.72 MAOB (0.58) MAOBADORA2BMAPTNPC1RAB9A
SCHEMBL13134176 0.72 MAOB (0.49) MAOBADORA2BMAPTNPC1RAB9A
Hydrochloric Acid SCHEMBL87683 0.72 MAOB (0.73) MAOBADORA2BMAPTNPC1RAB9A
SCHEMBL13655497 0.72 MAOB (0.62) MAOBADORA2BMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106986862-A Hepatitis c inhibitor and application thereof ABBVIE 公司 2017-07-28 CN disclosed
CN-103649079-B Hepatitis c inhibitor and application thereof ABBVIE 公司 2016-11-16 CN disclosed
EP-2655362-A1 HEPATITIS C INHIBITORS AND USES THEREOF Abbvie Inc. (US) 2013-10-30 EP disclosed
WO-2012087833-A1 HEPATITIS C INHIBITORS AND USES THEREOF ABBOTT LABORATORIES (US) 2012-06-28 WO disclosed